SHELLY KINDAHL: Open Payments
NPI 1588922918 · FLORENCE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$300 in 20 payments from 6 companies in 2025. Trend: 2023 $435 · 2024 $362 · 2025 $300
Food & beverage: $300
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 13 | $166 |
| LEO Pharma Inc. | 2 | $43 |
| Amgen Inc. | 2 | $40 |
| Lilly USA, LLC | 1 | $20 |
| Galderma Laboratories, L.P. | 1 | $16 |
| ABBVIE INC. | 1 | $14 |
Products named: COSENTYX, OTEZLA, ANZUPGO, EBGLYSS, ADBRY, NEMLUVIO, SKYRIZI.
Industry payments across AL — which companies pay providers there.
